Survival in 45 patients with crhonic granulomatous disease and invasive aspergillosis. (A) Overall survival of the 45 patients was 67.9% at 120 mo. (B) Median survival time for patients with XL-CGD was 167 mo and it was more than 313 mo for patients with AR-CGD (p = 0.07). (C) When survival analysis of the AR-CGD subgroups was performed, no significant differences were observed (p = 0.254).